Harmony Biosciences Holdings (HRMY) Profit After Tax (2019 - 2026)

Harmony Biosciences Holdings (HRMY) has 8 years of Profit After Tax data on file, last reported at $32.5 million in Q1 2026.

• For the quarter ending Q1 2026, Profit After Tax fell 28.97% year-over-year to $32.5 million; the trailing twelve-month figure through Mar 2026 stood at $145.6 million (down 5.19% YoY), and the FY2025 full-year result was $159.0 million, up 9.26% from the prior year.
• Profit After Tax climbed to $32.5 million in Q1 2026, from $22.5 million in the prior quarter.
• In the past five years, Profit After Tax ranged from a high of $87.9 million in Q3 2022 to a low of $11.5 million in Q2 2024.
• A 5-year average of $38.1 million and a median of $38.3 million in 2024 frame the typical range for Profit After Tax.
• Across the five-year window, Profit After Tax surged 1014.17% in 2022 and plunged 65.9% in 2024, its largest moves.
• Tracing HRMY's Profit After Tax over 5 years: stood at $48.5 million in 2022, then tumbled by 44.4% to $27.0 million in 2023, then jumped by 83.43% to $49.5 million in 2024, then slumped by 54.57% to $22.5 million in 2025, then soared by 44.55% to $32.5 million in 2026.
• Business Quant data shows HRMY's Profit After Tax at $32.5 million in Q1 2026, $22.5 million in Q4 2025, and $50.9 million in Q3 2025.